成長因子β-活性化キナーゼ1信号伝達経路の変換は,心筋の生存と再構成を決定的に調節する
Lei Li1, Yi Chen1, Jessica Doan1
1From the Department of Physiology and Biophysics, University of Washington, Seattle, WA (L.L., Y.C., J.D., J.M., Q.L.); and Howard Hughes Medical Institute, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH (J.D.M.).
Circulation
|October 4, 2014
まとめ
成長因子β活性化キナーゼ1 (TAK1) を変換することは,心臓の健康に不可欠です. その欠如はプログラムされた死滅 (necroptosis) を誘発し,心不全とマウスの有害な改造につながります.
科学分野:
- 心血管生物学 心血管生物学
- 細胞死メカニズム 細胞死メカニズム
- 分子シグナリング
背景:
- プログラムされた死滅 (necroptosis) は,発達と疾患において極めて重要であるが,その心臓の調節は不明である.
- 筋臓の改造と心不全におけるネクロプトーシスの役割については,さらなる調査が必要である.
研究 の 目的:
- 成長因子β活性化キナーゼ1 (TAK1) の変換が心臓死滅を調節する役割を調査する.
- TAK1が心筋の再編成と心不全に影響を与える分子メカニズムを解明する.
主な方法:
- マウスのマップ3k7 (TAK1をコードする) の心臓特異的遺伝子アブレーション.
- ミオサイトアポトーシスとネクロプトーシスの分析.
- 心筋再建と心不全マーカーの評価.
- 腫瘍死滅因子受容体-1 (TNFR1) 信号伝達経路の調査.
主要な成果:
- 心臓特異的なMap3k7アブレーションにより,自発的なアポトーシスとネクロプトーシスが誘発され,有害なリモデリングと心不全を引き起こしました.
- これらの効果はTNFR1の信号伝達に依存していた.
- TAK1はTNFR1シグナル伝達における分子スイッチとして作用し,RIP1,FADD,カスパース8を含む細胞死複合体の形成を調節する.
- RIP1またはRIP3の阻害は,TAK1欠乏したマウスの死滅性細胞死亡と心不全を改善しました.
結論:
- TAK1は心臓における重要な生存因子であり,死滅を直接抑制する.
- TAK1は,心筋ホメオスタシスを維持し,有害な改造を防ぐために不可欠です.
- TAK1媒介性ネクロプトーシス経路をターゲットにすることで,心不全の治療戦略を提供することができる.
関連する概念動画
TGF - β Signaling Pathway
7.1K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.1K
MAPK Signaling Cascades
7.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
PI3K/mTOR/AKT Signaling Pathway
5.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.1K
Interactions Between Signaling Pathways
4.6K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.6K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Regulation of Angiogenesis and Blood Supply
2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K


